Open AccessAssociation of serum annexin A1 with treatment response and prognosis in patients with esophageal squamous cell carcinoma
Author(s) -
Gaohua Han,
Kai Lü,
Jian Huang,
Lixin Zhang,
Shengbin Dai,
Chenyang Dai
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.187297
Subject(s) - annexin a1 , medicine , chemoradiotherapy , hazard ratio , gastroenterology , confidence interval , oncology , overall survival , annexin , pathology , staining
Annexin A1 (ANXA1), a calcium-dependent phospholipid binding protein, is known to be regulated by microRNA-196a (miR-196a) in esophageal adenocarcinoma, and its high expression in tumor tissue is correlated with the poor prognosis of esophageal squamous cell carcinoma (ESCC). However, the role of ANXA1 in the serum of patients with ESCC remains unclear.